However, the present studies demonstrate that OCT4 exerts dual effects in breast cancer,5, 20 which may be related to the multiple intrinsic genes involved in different breast cancer subtypes, especially estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor 2 (HER2). Here, PGR is linked to breast cancer.